Zobrazeno 1 - 10
of 118
pro vyhledávání: '"Elizabeth Blaney"'
Publikováno v:
The American Journal of Medicine. 135:S20-S23
Amyloidosis is a heterogeneous disease that can cause a wide array of nonspecific symptoms when the gastrointestinal (GI) tract is involved, including weight loss, early satiety, change in bowel habits with diarrhea, constipation, or alternating bowe
Autor:
Susan E. Morgan-Lappe, Zev A. Wainberg, Ramesh K. Ramanathan, Huibin Yue, Martha Elizabeth Blaney, Louie Naumovski, John H. Strickler, Lan Wang, John Nemunaitis, George W. Sledge, Erika Hamilton, Sreeneeranj Kasichayanula, Minal A. Barve, Michael S. Gordon, Monica Motwani
Publikováno v:
Molecular cancer therapeutics, vol 20, iss 10
Dilpacimab (formerly ABT-165), a novel dual-variable domain immunoglobulin, targets both delta-like ligand 4 (DLL4) and VEGF pathways. Here, we present safety, pharmacokinetic (PK), pharmacodynamic (PD), and preliminary efficacy data from a phase I s
Publikováno v:
The American journal of surgical pathology. 44(8)
Intestinal inertia is a severe form of gut dysmotility that may require surgical resection. Loss of myenteric ganglion cells has been proposed as a possible etiology. Preclinical models have also suggested that virus infection-associated ganglionitis
Autor:
John T. Page
Publikováno v:
Notes and Queries. :93-93
Autor:
Jordi Bruix, Talia Golan, Gregory Vosganian, Kathy D. Miller, Anthony W. Tolcher, Susan Lacy, Satwant Lally, Toshio Shimizu, Arjun Vasant Balar, Stacie Lambert, John D. Powderly, Martha Elizabeth Blaney, Xiaowen Guan, Rachel S Leibman, Patricia LoRusso, Albiruni Ryan Abdul Razak, Loren S. Michel
Publikováno v:
Cancer Research. 81:CT207-CT207
Background Glycoprotein-A repetitions predominant (GARP) regulates membrane-bound transforming growth factor β1 (TGFβ1), an immunosuppressive cytokine. ABBV-151 is a first-in-class monoclonal antibody (mAb) that binds to the GARP-TGFβ1 complex and
Autor:
M. Nagasaka, Martha Elizabeth Blaney, T. Dai, J. Grewal, Stacie Lambert, Y. Li, Missak Haigentz, Aru Panwar, C. Maurice-Dror, Daniel Da Costa, I. Moreno, Maulik Patel, Ari Rosenberg, Jordan Berlin, C. Le Tourneau, I. Gluck, Michael A. McDevitt, Xiuning Le, Kathryn A. Gold, Maura L. Gillison
Publikováno v:
Annals of Oncology. 31:S685
Autor:
Kathy D. Miller, Stacie Lambert, Albiruni Ryan Abdul Razak, Satwant Lally, Talia Golan, Toshio Shimizu, Arjun Vasant Balar, Jordi Bruix, Anthony W. Tolcher, Patricia LoRusso, Rachel S Leibman, Susan Lacy, John D. Powderly, Martha Elizabeth Blaney, Loren S. Michel, Gregory Vosganian, X. Guan
Publikováno v:
Annals of Oncology. 31:S499
Autor:
Talia Golan, Kathy D. Miller, Michael A. McDevitt, Anthony W. Tolcher, John D. Powderly, Daniel Dacosta, Patricia LoRusso, Martha Elizabeth Blaney, William R Henner
Publikováno v:
Journal of Clinical Oncology. 38:TPS3147-TPS3147
TPS3147 Background: CD40 is a key costimulatory molecule for both the innate and adaptive immune systems that is essential for T-cell activation and proliferation. OX40 is a costimulatory molecule that is involved in enhancing nascent immune response
Autor:
Eric P. Winer, Amy C. Peterson, Javier Cortes, Vandana G. Abramson, Tiffany A. Traina, Maureen E. Trudeau, Joyce O'Shaughnessy, Denise A. Yardley, Peter Schmid, Martha Elizabeth Blaney, Lee S. Schwartzberg, Joyce Steinberg, Catherine M. Kelly, Rita Nanda, Iulia Cristina Tudor, Ahmad Awada, Clifford A. Hudis
Publikováno v:
Cancer Research. 75:P5-19
Background AR expression has been observed in 10-30% of patients with TNBC. AR+ TNBC cell lines demonstrated enhanced growth in response to androgen stimulation that is inhibited by enzalutamide (ENZA), a potent oral inhibitor of AR signaling. AR+ TN
Autor:
Martha Elizabeth Blaney, Huibin Yue, Louie Naumovski, Sreeneeranj Kasichayanula, John H. Strickler, Lan Wang, Monica Motwani, Zev A. Wainberg
Publikováno v:
Annals of Oncology. 29:v83-v84